215 related articles for article (PubMed ID: 34862332)
1. A low aldosterone/renin ratio and high soluble ACE2 associate with COVID-19 severity.
Akin S; Schriek P; van Nieuwkoop C; Neuman RI; Meynaar I; van Helden EJ; Bouazzaoui HE; Baak R; Veuger M; Mairuhu RATA; van den Berg L; van Driel V; Visser LE; de Jonge E; Garrelds IM; Duynstee JFAB; van Rooden JK; Ludikhuize J; Verdonk K; Caliskan K; Jansen T; van Schaik RHN; Danser AHJ
J Hypertens; 2022 Mar; 40(3):606-614. PubMed ID: 34862332
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
[TBL] [Abstract][Full Text] [Related]
3. Impact of Salt Intake and Renin-Angiotensin-Aldosterone System Blockade on Lung Severe Acute Respiratory Syndrome Coronavirus 2 Host Factors.
Zhang X; Liu L; Gaballa MMS; Hasan AA; Xiong Y; Xie L; Klein T; Delic D; Kleuser B; Krämer BK; Li J; Hocher B
Kidney Blood Press Res; 2022; 47(9):565-575. PubMed ID: 35878596
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS).
Cadegiani FA; Goren A; Wambier CG
Med Hypotheses; 2020 Oct; 143():110112. PubMed ID: 32721806
[TBL] [Abstract][Full Text] [Related]
5. Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19.
Rieder M; Wirth L; Pollmeier L; Jeserich M; Goller I; Baldus N; Schmid B; Busch HJ; Hofmann M; Kern W; Bode C; Duerschmied D; Lother A
Am J Hypertens; 2021 Apr; 34(3):278-281. PubMed ID: 33043967
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease.
Khoury EE; Knaney Y; Fokra A; Kinaneh S; Azzam Z; Heyman SN; Abassi Z
J Cell Mol Med; 2021 Apr; 25(8):3840-3855. PubMed ID: 33660945
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis.
Saengsiwaritt W; Jittikoon J; Chaikledkaew U; Udomsinprasert W
Rev Med Virol; 2022 Jul; 32(4):e2323. PubMed ID: 34997794
[TBL] [Abstract][Full Text] [Related]
8. Soluble ACE2 and TMPRSS2 Levels in the Serum of Asthmatic Patients.
Lee JH; Lee CE; Yoo Y; Shin E; An J; Park SY; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
J Korean Med Sci; 2022 Feb; 37(8):e65. PubMed ID: 35226423
[TBL] [Abstract][Full Text] [Related]
9. Genetic Association between ACE2 (rs2285666 and rs2074192) and TMPRSS2 (rs12329760 and rs2070788) Polymorphisms with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors.
Fernández-de-Las-Peñas C; Arendt-Nielsen L; Díaz-Gil G; Gómez-Esquer F; Gil-Crujera A; Gómez-Sánchez SM; Ambite-Quesada S; Palomar-Gallego MA; Pellicer-Valero OJ; Giordano R
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360172
[TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
[TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.
Kutz A; Conen A; Gregoriano C; Haubitz S; Koch D; Domenig O; Bernasconi L; Mueller B; Schuetz P
Eur J Endocrinol; 2021 Apr; 184(4):543-552. PubMed ID: 33539316
[TBL] [Abstract][Full Text] [Related]
12. Obesogenic and Ketogenic Diets Distinctly Regulate the SARS-CoV-2 Entry Proteins ACE2 and TMPRSS2 and the Renin-Angiotensin System in Rat Lung and Heart Tissues.
Da Eira D; Jani S; Ceddia RB
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684358
[TBL] [Abstract][Full Text] [Related]
13. Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.
Fließer E; Birnhuber A; Marsh LM; Gschwandtner E; Klepetko W; Olschewski H; Kwapiszewska G
J Pathol Clin Res; 2021 Sep; 7(5):446-458. PubMed ID: 33978304
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.
Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L
Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695
[TBL] [Abstract][Full Text] [Related]
15. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
[TBL] [Abstract][Full Text] [Related]
16. Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin-angiotensin-aldosterone system on COVID-19 disease.
Zobel CM; Kuhn H; Schreiner M; Wenzel W; Wendtland J; Goekeri C; Scheit L; Oltmanns K; Rauschning D; Grossegesse M; Hofmann N; Wirtz H; Spethmann S;
Virol J; 2024 Jan; 21(1):15. PubMed ID: 38200555
[TBL] [Abstract][Full Text] [Related]
17.
Abdelsattar S; Kasemy ZA; Ewida SF; Abo-Elsoud RAA; Zytoon AA; Abdelaal GA; Abdelgawad AS; Khalil FO; Kamel HFM
Br J Biomed Sci; 2022; 79():10238. PubMed ID: 35996506
[No Abstract] [Full Text] [Related]
18. Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers.
Lundström A; Ziegler L; Havervall S; Rudberg AS; von Meijenfeldt F; Lisman T; Mackman N; Sandén P; Thålin C
J Med Virol; 2021 Oct; 93(10):5908-5916. PubMed ID: 34138483
[TBL] [Abstract][Full Text] [Related]
19. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
[TBL] [Abstract][Full Text] [Related]
20. Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients.
Rahman MM; Hasan M; Ahmed A
Rev Med Virol; 2021 Sep; 31(5):1-12. PubMed ID: 33426683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
